medigraphic.com
ISSN 0188-9796 (Impreso)

2011, Número 2

<< Anterior

Rev Endocrinol Nutr 2011; 19 (2)


Seguimiento a largo plazo de pacientes con cáncer papilar y folicular de tiroides. Estudio prospectivo de 715 pacientes

Sosa-Caballero A

Idioma: Español
Referencias bibliográficas: 8
Paginas: 87-89
Archivo PDF: 76.39 Kb.


FRAGMENTO

Objetivo: Evaluar la tasa de recurrencia de los pacientes con cáncer diferenciado de tiroides (CDT) mediante un ensayo ultrasensible para tiroglobulina (Tg), realizando mediciones bajo tratamiento con levotiroxina (LT4) y con el efecto de la hormona estimulante de tiroides (TSH) por suspensión de la LT4 o con la TSH recombinante humana (rhTSH).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlageter MH, Claustrat S, Koscienly S, Taieb D, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Torlontano M, Tenebaum F, Bardet S, Bussiere F, Girad JJ, Morel O, Schnnegans O, Schlienger JL, Prost A, So D, Archmbeaud F, Ricard M, Benhamou E. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007; 92: 2487-2495.

  2. Lervasi A, Lervasi G, Bottoni A, Annicchiarico C, Cecco P Di, Zucchelli GC. Diagnostic performance of a new highly sensitive thyroglobulin immunoassay. J Endocrinol 2004; 182: 287-294.

  3. www.beckmancoulter.com/bulletin9073g

  4. Castagna MG, Tala HP, Cipri C, Belardini V, Fioravanti C, Pasqui L, Sestini F, Theodoropoulou A, Pacini F. The use of ultrasensitive thyroglobulin assays reduces but not abolishes the need for TSH stimulation in patients with differentiated thyroid carcinoma. J Endocrinol Invest 2011 as DOI: 10.3275/7571.

  5. Mazzaferri EL. Will highly sensitive thyroglobulin assays change the management of thyroid cancer? Clin Endocrinol (Oxf) 2007; 67: 321-323.

  6. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 3668-3673.

  7. Giovanella L. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management. Clin Chem Lab Med 2008; 46: 1067-1073.

  8. Rosario PW, Purisch S. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/mL determined by traditional assays? Clin Endocrinol (Oxf) 2008; 68: 338-342.




2020     |     www.medigraphic.com